BG Medicine to Present at the JMP Securities Healthcare Conference

WALTHAM, Mass., July 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that it will present at the upcoming JMP Securities Healthcare Conference on Friday, July 13, 2012 at 11:30 a.m. Eastern Time. Eric Bouvier, President and CEO of the Company, will present an overview of BG Medicine. The corporate presentation will be available to the public through a webcast accessible by visiting: http://wsw.com/webcast/jmp18/bgmd/ or the "Investors" section of the Company's website at www.bg-medicine.com. Replays will be available for 30 days after the presentation.